The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Studies

• Asıl Yazarlar: Sandy Estrada (Yazar), Thomas P. Lodise (Yazar), Glenn S. Tillotson (Yazar), Dino Delaportas (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Adis, Springer Healthcare, 2020-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Oritavancin is a FDA-approved single-dose IV therapy for the treatment of acute bacterial skin and skin structure infections caused (or suspected to be caused) by certain Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Published data describ...